98%
921
2 minutes
20
Folate-mediated one-carbon metabolism (FOCM) is an interconnected network of metabolic pathways, including those required for the de novo synthesis of dTMP and purine nucleotides and for remethylation of homocysteine to methionine. Mouse models of folate-responsive neural tube defects (NTDs) indicate that impaired de novo thymidylate (dTMP) synthesis through changes in SHMT expression is causative in folate-responsive NTDs. We have created a hybrid computational model comprised of ordinary differential equations and stochastic simulation. We investigated whether the de novo dTMP synthesis pathway was sensitive to perturbations in FOCM that are known to be associated with human NTDs. This computational model shows that de novo dTMP synthesis is highly sensitive to the common MTHFR C677T polymorphism and that the effect of the polymorphism on FOCM is greater in folate deficiency. Computational simulations indicate that the MTHFR C677T polymorphism and folate deficiency interact to increase the stochastic behavior of the FOCM network, with the greatest instability observed for reactions catalyzed by serine hydroxymethyltransferase (SHMT). Furthermore, we show that de novo dTMP synthesis does not occur in the cytosol at rates sufficient for DNA replication, supporting empirical data indicating that impaired nuclear de novo dTMP synthesis results in uracil misincorporation into DNA.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429759 | PMC |
http://dx.doi.org/10.1038/s41598-017-00854-w | DOI Listing |
Objectives: Vitamin B12 plays a vital role in folate-mediated one-carbon metabolism (FOCM), a series of one-carbon transfer reactions that generate nucleotides (thymidylate (dTMP) and purines) and methionine. Inadequate levels of B12 impair FOCM, depressing de novo thymidylate (dTMP) synthesis, which in turn leads to uracil accumulation in DNA. This phenomenon has been well documented in nuclear DNA.
View Article and Find Full Text PDFMol Divers
August 2025
Faculty of Pharmacy, Integral University, Lucknow, UP, 226026, India.
Rising cases of drug resistance tuberculosis including multidrug-resistant and extensively drug-resistant emphasize the need for development of drugs with novel mechanism of action. The study aimed to explore novel inhibitors targeting Mycobacterium thymidine monophosphate kinase (Mtb TMPK), a promising but unexplored drug target for tuberculosis treatment. A library of 200 coumarin derivatives was rationally designed and screened against Mtb TMPK, an essential enzyme in nucleotide biosynthesis of mycobacterium tuberculosis.
View Article and Find Full Text PDFInsect Sci
August 2025
School of Life Sciences, Anhui Agricultural University, Hefei, China.
Dihydrofolate reductase (DHFR), a pivotal enzyme in folate metabolism and DNA synthesis, is a well-established cancer therapeutic target. However, its non-canonical roles in developmental signaling and evolutionary-conserved functions in non-mammalian species remain poorly characterized. Using the lepidopteran model Bombyx mori, this study uncovered the pleiotropic functions of BmDHFR in midgut proliferation and lipid homeostasis through dual metabolic and Hedgehog (Hh) signaling regulation.
View Article and Find Full Text PDFPestic Biochem Physiol
September 2025
National Key Laboratory of Veterinary Public Health Security, National Animal Protozoa Laboratory and College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. Electronic address:
Toxoplasma gondii is a significant zoonotic pathogen that infects nearly all warm-blooded animals. Available drugs for clinical treatment of toxoplasmosis are limited, creating an urgent need for development of new compounds. Toltrazuril (TOL) is a highly effective and broad-spectrum drug against parasites in Apicomplexa.
View Article and Find Full Text PDFAm J Med Genet A
July 2025
Department of Medical Genetics, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
Childhood-onset neurodegeneration with progressive microcephaly (CONPM) is a rare autosomal recessive disorder caused by pathogenic variants in the DTYMK gene. This ultra-rare condition is characterized by progressive neurological regression, epilepsy, severe microcephaly, and global cerebral atrophy. Only four cases have been reported in the literature to date.
View Article and Find Full Text PDF